NCT03721068 2025-09-09
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
UNC Lineberger Comprehensive Cancer Center
Shenzhen Geno-Immune Medical Institute